Legislative Advocacy



Action Network

NBCC Programs

NBCC Annual Advocacy Summit

Project LEAD

 2021 Texas Legislative Priorities


Priority #1

ABCF is urging continued support of The Breast and Cervical Cancer Services (BCCS) program, as well as support of funding for the Medicaid Breast and Cervical Cancer Treatment Act (MBCC). After September 1, 2017 women receiving Medicaid through the Medicaid for Breast and Cervical Cancer (MBCC) program get their services from the STAR+PLAN managed care program. People in the STAR+PLAN program pick a health plan as well as a primary care provider or clinic. ABCF urges Texas legislators to protect the MBCC breast cancer treatment services with no additional costs for uninsured low-income women diagnosed with breast cancer in the STAR+PLAN.


Priority 2

The Alamo Breast Cancer Foundation is urging support for the continuation of Cancer Prevention and Research Institute of Texas, CPRIT.  It is of utmost importance to Alamo Breast Cancer Foundation that citizens of Texas benefit from CPRIT innovative research projects focusing on immediate and translational outcomes leading to cures, and better treatments. The prevention and early detection services CPRIT provides reduces the risks of developing and dying from cancer. Protect the health and welfare of all Texans and support the continuation of CPRIT.


Priority 3

ABCF supports affordable and accessible health care for all Americans. Health insurance should not be denied because of a pre-existing condition.  Individuals with a pre-existing condition should not be charged higher premiums.  ABCF supports the Affordable Care Act and Medicaid Expansion.


Priority 4

ABCF urges removal of verbiage in the Texas State published “Women’s Right to Know Brochure” stating a link between abortion and breast cancer as this is not an evidence- based statement.

Priority 5

ABCF urges support of the Medically Necessary Fertility Preservation Act HB 293 and SB 93.  Requires insurers to cover fertility preservation procedures for cancer patients and others who are facing potential infertility as a result of medical treatment.